Skip to content
Recall Observatory FDA recall evidence

Drug product

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

D-0244-2026

December 19, 2025

Class II

Product summary

Firm
Novo Nordisk Inc.
Event
Event 98100
Status
Ongoing
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0244-2026

Official wording

Reason: Presence of Particulate Matter: Hair was found in a prefilled syringe

Code information: Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026

Distribution pattern: Nationwide within the United States.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter